Research Antibodies and Reagents Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global research antibodies and reagents market.
This report focuses on research antibodies and reagents market which is experiencing strong growth. The report gives a guide to the research antibodies and reagents market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Where is the largest and fastest growing market for the research antibodies and reagents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Research Antibodies and Reagents market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider research antibodies and reagents market, and compares it with other markets.
1) By Technology: Western Blot; Immunofluorescence; Immunohistochemistry; Flow Cytometry; Enzyme-linked Immunosorbent Assay (ELISA); Multiplex Immunosorbent Assay; Immunoprecipitation; Others
2) By Application: Proteomics; Drug Discovery & Development; Genomics
3) By End-User: Pharmaceutical & Biotechnology Industry; Academic & Research Institutes; Contract Research Organizations (CROs)
Companies Mentioned: Abcam plc.; Merck KGaA; Cell Signaling Technology Inc.; GE Healthcare; Thermo Fisher Scientific Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
This report focuses on research antibodies and reagents market which is experiencing strong growth. The report gives a guide to the research antibodies and reagents market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
- Create regional and country strategies on the basis of local data and analysis
- Identify growth segments for investment
- Outperform competitors using forecast data and the drivers and trends shaping the market
- Understand customers based on the latest market research findings
- Benchmark performance against key competitors
- Utilize the relationships between key data sets for superior strategizing
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the research antibodies and reagents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Research Antibodies and Reagents market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider research antibodies and reagents market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth
- Market segmentations break down market into sub markets
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
- The research antibodies and reagents market section of the report gives context. It compares the research antibodies and reagents market with other segments of the research antibodies and reagents market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, research antibodies and reagents indicators comparison
Scope
Markets Covered:
1) By Technology: Western Blot; Immunofluorescence; Immunohistochemistry; Flow Cytometry; Enzyme-linked Immunosorbent Assay (ELISA); Multiplex Immunosorbent Assay; Immunoprecipitation; Others
2) By Application: Proteomics; Drug Discovery & Development; Genomics
3) By End-User: Pharmaceutical & Biotechnology Industry; Academic & Research Institutes; Contract Research Organizations (CROs)
Companies Mentioned: Abcam plc.; Merck KGaA; Cell Signaling Technology Inc.; GE Healthcare; Thermo Fisher Scientific Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Frequently Asked Questions about the Global Research Antibodies and Reagents Market
What is the estimated value of the Global Research Antibodies and Reagents Market?
What is the growth rate of the Global Research Antibodies and Reagents Market?
What is the forecasted size of the Global Research Antibodies and Reagents Market?
Who are the key companies in the Global Research Antibodies and Reagents Market?
Table of Contents
1. Executive Summary2. Research Antibodies and Reagents Market Characteristics3. Research Antibodies and Reagents Market Trends And Strategies4. Impact Of COVID-19 On Research Antibodies and Reagents28. Research Antibodies and Reagents Pipeline Analysis29. Key Mergers And Acquisitions In The Research Antibodies and Reagents Market30. Research Antibodies and Reagents Market Future Outlook and Potential Analysis
5. Research Antibodies and Reagents Market Size And Growth
6. Research Antibodies and Reagents Market Segmentation
7. Research Antibodies and Reagents Market Regional And Country Analysis
8. Asia-Pacific Research Antibodies and Reagents Market
9. China Research Antibodies and Reagents Market
10. India Research Antibodies and Reagents Market
11. Japan Research Antibodies and Reagents Market
12. Australia Research Antibodies and Reagents Market
13. Indonesia Research Antibodies and Reagents Market
14. South Korea Research Antibodies and Reagents Market
15. Western Europe Research Antibodies and Reagents Market
16. UK Research Antibodies and Reagents Market
17. Germany Research Antibodies and Reagents Market
18. France Research Antibodies and Reagents Market
19. Eastern Europe Research Antibodies and Reagents Market
20. Russia Research Antibodies and Reagents Market
21. North America Research Antibodies and Reagents Market
22. USA Research Antibodies and Reagents Market
23. South America Research Antibodies and Reagents Market
24. Brazil Research Antibodies and Reagents Market
25. Middle East Research Antibodies and Reagents Market
26. Africa Research Antibodies and Reagents Market
27. Research Antibodies and Reagents Market Competitive Landscape And Company Profiles
31. Appendix
Executive Summary
Major players in the research antibodies and reagents market are Becton Dickinson and Company, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann La-Roche Ltd., Merck KGaA, PerkinElmer Inc., Lonza Group AG, Abcam plc., GenScript Biotech Corporation and Bio-Techne Corporation.The global research antibodies and reagents market is expected to grow from $12.40 billion in 2021 to $13.19 billion in 2022 at a compound annual growth rate (CAGR) of 6.3%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The market is expected to reach $16.90 billion in 2026 at a CAGR of 6.4%
The research antibodies and reagents market consist of sales of research antibodies, reagents and related services by entities (organizations, sole traders and partnerships) that produce research antibodies and reagents to diagnose and treat different diseases. The revenue generated by the market includes the sales of research antibodies in the form of primary and secondary antibodies extracted from sources such as mouse, rabbit and others, and reagents like stains & dyes, media & serum, fixatives, buffers, probe, solvents, enzymes and others. The companies involved in the research antibodies and reagents market are primarily engaged in developing antibodies and reagents for the application of proteomics, genomics, drug discovery and development by the pharmaceutical & biotechnology industries, academic & research institutes and contract research organizations.
The main types of technologies in research antibodies and reagents are western blot, immunofluorescence, immunohistochemistry, flow cytometry, enzyme-linked immunosorbent assay (ELISA), multiplex immunosorbent assay, immunoprecipitation and others. The western blot, also known as western blotting, is a molecular biology and immunogenetics analytical technique for detecting specific proteins in a sample of tissue homogenate or extract. The different applications include proteomics, drug discovery & development, genomics and implemented in various sectors such as pharmaceutical & biotechnology industry, academic & research institutes, contract research organizations (CROs).
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Increasing investment in medical and health research and development (R&D) is predicted to contribute to the growth of the research antibodies and reagents market. In the field of life science research, antibodies and reagents are essential components for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing. According to the American Association for the Advancement of Science’s (AAAS) statistics published in December 2019, the total investment in medical and health research in the US grew by 6.4%. The health industry invested $129.5 billion (66.7%), followed by federal agencies investments of $43 billion (22.2%), and $21.7 billion (11.2%) invested by foundations, state & local governments, academic research institutions, and voluntary health associations. Thus, increasing investment in healthcare research and development will increase the utilization of research antibodies and reagents.
Reproducibility issues of antibodies and reagents is expected to hamper the growth of the research antibodies and reagents market. Reproducibility is the ability of an experiment or calculation to be duplicated by other researchers working independently. The prevalence of irreproducible preclinical research exceeded 50%, resulting in approximately $28 billion spent on preclinical research every year. Among the irreproducible research, the largest fraction of about 36% is assigned to biological reagents, which amounts to $10 billion annually. This huge research wastage expenses are due to insufficiently validated antibodies and irreproducible reagents that are not appropriate for the target proteins. Thus, reproducibility issues of antibodies and reagents are expected to restrain the market growth.
Technological advancements in the area of purification of antibodies and reagents show opportunities for the growth of the research antibodies and reagents market during the forecast period. Irreproducible antibodies and reagents are a major challenge for the industry as this will affect the outcome of the research. In 2019, Genscript announced the launch of an AmMag technology, which is a semi-automatic purification instrument that accelerates the purification process from days to hours. The AmMag SA was developed under the license agreement with Amgen.
In 2019, LifeSpan BioSciences Inc, a US-based global molecular pathology company, acquired Everest Biotech Ltd for an undisclosed amount. The acquisition is expected to strengthen LifeSpan Biosciences' position in the research reagent market and will broaden the product portfolio over 500,000 monoclonal and polyclonal primary antibodies to include virtually every protein in the proteome. Everest Biotech is a UK-based anti-peptide and antigen affinity purified goat polyclonal antibodies manufacturer, which was established in 2000.
The countries covered in the research antibodies and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Becton Dickinson and Company
- Thermo Fisher Scientific inc.
- Bio-Rad Laboratories inc.
- F.Hoffmann La-Roche Ltd.
- Merck KGaA
- PerkinElmer inc.
- Lonza Group AG
- Abcam plc.
- GenScript Biotech Corporation
- Bio-Techne Corporation
- Teva Pharmaceutical Industries Limited
- Santa Cruz Biotechnology inc.
- BioLegend inc.
- Rockland Immunochemicals inc.
- Johnson & Johnson
- Eli Lily and Company
- Agilent Technologies inc.
- Danaher Corporation
- Cell Signaling Technology inc.
- GE Healthcare
- Amgen inc.
- Sanofi
- QIAGEN
- Luminex Corporation
- Dako
- Alere inc.
- Abbott
Methodology
LOADING...
